Multi-omics analysis identified ASRGL1 as a novel oncogene and potential therapeutic target in prostate cancer
American Journal of Clinical and Experimental Urology · 2026 · 14 (5) · 189-203
DOI: 10.62347/bumq2278 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Urology, 2026. Verfasst von Yuan Ma und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ma, Y., Fan, R., Yu, W., Duan, K., Lin, G., Chen, Z., & Li, G. (2026). Multi-omics analysis identified ASRGL1 as a novel oncogene and potential therapeutic target in prostate cancer. American Journal of Clinical and Experimental Urology, 14(5), 189-203. https://doi.org/10.62347/bumq2278
Vancouver
Ma Y, Fan R, Yu W, Duan K, Lin G, Chen Z, et al. Multi-omics analysis identified ASRGL1 as a novel oncogene and potential therapeutic target in prostate cancer. American Journal of Clinical and Experimental Urology. 2026;14(5):189-203. doi:10.62347/bumq2278
BibTeX
@article{Ma2026,
author = {Ma, Yuan and Fan, Rong and Yu, Wenyue and Duan, Kefei and Lin, Gaoteng and Chen, Zheng and Li, Guizhong},
title = {Multi-omics analysis identified ASRGL1 as a novel oncogene and potential therapeutic target in prostate cancer},
journal = {American Journal of Clinical and Experimental Urology},
year = {2026},
volume = {14},
number = {5},
pages = {189--203},
doi = {10.62347/bumq2278}
}
EUVIMED